Labcorp Holdings Inc. (lh)
LH Estimates
Public analyst price targets and consensus snapshot for Labcorp Holdings Inc.. Deeper estimate history and models are available in Vest Terminal.
| Last price | $303.98 |
| Analyst mean target | $344.81 |
| Analyst high target | $385.00 |
| Analyst low target | $293.00 |
| Upside vs mean target | 13.4% |
| Consensus recommendation | Buy |
| Number of analysts | 16 |
| Forward P/E | 15.32 |
Start Free — open LH in Vest Terminal
Access live data, filings, ownership, and analysis for Labcorp Holdings Inc..
Labcorp Holdings Inc. FAQ
What does Labcorp Holdings Inc. (LH) do?
Labcorp Holdings Inc. provides laboratory services. It operates in Diagnostics Laboratories and Biopharma Laboratory Services segments. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PS…
What is LH's P/E ratio?
Labcorp Holdings Inc. has a trailing P/E of 25.87× based on publicly available market data.
Does LH pay a dividend?
Indicated dividend yield: 0.9%. Confirm ex-dates and payout history in Vest Terminal.
What sector is LH in?
Labcorp Holdings Inc. is classified in Healthcare (Diagnostics & Research) on NYQ.
What is LH's market capitalization?
Approximate market cap: $24.65B.
What are the main risks for LH?
Standard market, competitive, and execution risks apply; see the Risks section.
What are the strengths of LH?
Potential positives include revenue growth of 5.8% year-over-year, earnings growth of 28.2% year-over-year.
Where can I get analyst estimates for LH?
Public analyst price targets and consensus for Labcorp Holdings Inc. are on the free /stocks/lh/estimates page. Deeper estimate history and models are available in Vest Terminal.